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Radiation exposure and pregnancy
Palma Shaw, MD,a Audra Duncan, MD,b Ageliki Vouyouka, MD,c and Kathleen Ozsvath, MD,d Boston,
Mass; Rochester, Minn; and New York and Albany, NY
Introduction: The effect of radiation on the fetus has been derived primarily from animal studies and human exposures to
diagnostic and therapeutic radiation as well as atomic bomb exposure. Given the variety of sources, there is controversy
over the dose of radiation in addition to the other environmental conditions that surrounded these events and their
relationship to exposure today.
Methods: The effects of ionizing radiation on the fetus, the prenatal period, parental exposure, the pregnant clinician, and
the pregnant patient are discussed in the context of their exposure to radiation.
Results:The fetus is most sensitive to radiation effects between 8 and 15weeks of pregnancy. Stepping away from the table
and using movable shields help reduce the exposure by a factor of four for every doubling of the distance between the
operator and the radiation source.
Conclusion: Proposed guidelines for pregnancy during vascular residency training involving fluoroscopic procedures can
help bring about awareness, clarify maximal exposure, and better delineate the role of the pregnant resident. ( J Vasc Surg
2011;53:28S-34S.)RADIATION EFFECTS ON THE FETUS
The effect of radiation on the fetus has been derived
from animal studies, human exposures to diagnostic and
therapeutic radiation, to atomic bomb radiation at Hiro-
shima and Nagasaki in 1945, and to the fallout of the
Chernobyl nuclear power plant explosion in April 1986. It
is important to appreciate that much of the information is
taken from the exposure of large populations at Hiroshima
and Nagasaki. Of the 2800 pregnant women exposed,
500 of their fetuses received10 mGy (1 rad) of radiation.
The offspring of these women were assessed in the context
of the amount of radiation received and the timing of the
exposure during their development. Multiple factors have
raised questions of whether the effects were solely due to
the radiation. Those factors include controversy over the
dose of radiation, the influence of neutron radiation, and
other environmental conditions surrounding this event.1-9
Effects of ionizing radiation on the fetus. Radiation
risks throughout pregnancy are related to the stage of
pregnancy and the absorbed dose. Potential radiation ef-
fects vary, depending on the fetal stage of development and
the magnitude of the doses.10 These risks are more signif-
icant during organogenesis and in the early fetal period,
somewhat less in the second trimester, and least in the third
trimester. Malformations have a threshold of 100 to 200
mGy or higher and are typically associated with central
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28Snervous system problems. For example, fetal doses of 100
mGy are not reached even with 3 pelvic computed tomog-
raphy (CT) scans or 20 conventional diagnostic x-ray ex-
aminations; however, these levels can be reached with
fluoroscopically guided interventional procedures of the
pelvis and with radiotherapy.11
Osei et al12 performed a retrospective study assessing
the radiation exposure in 50 pregnant women who under-
went radiologic examinations of the lower abdomen and
pelvis with the fetus near or in the field. The follow-up data
spanned 10 years. The radiation-absorbed dose was esti-
mated and varied between 0.01 Gy and 117 mGy.
Gestational ages were between 2 and 24 weeks, with 68% at
8 weeks, and 18% in the period of gestation (8 to 15
weeks), a point at which the concern for mental retardation
is raised. Two fetuses received total doses 100 mGy.
The authors used risk coefficients to estimate risks after
in utero exposure to diagnostic x-rays. At 8 to 15 weeks
after conception, the decline in intelligence quotient (IQ)
was estimated to be 30 IQ points/Gy.13 The estimate for
hereditary effects in all future generations was assumed to
be 2.4  102 per Gy. Total risk of fatal childhood cancer
at age 15 years as the result of prenatal exposure was
3.0  102 per Gy. The natural risk of fatal childhood
cancers in this geographic area to age 15 years was 7.7 
104.14 These authors concluded that for the risk of death,
malformation, and mental retardation, diagnostic radiologic
studies pose very small risk to the fetus.
For the induction of deterministic effects per radio-
graphic examination, the reported threshold doses are ap-
proached by CT pelvis examination with mean fetal dose of
89 mGy. They noted that increased genetic risk of 2 
103 for an individual fetus was associated with the highest
dose from diagnostic procedures, and this is small com-
pared with the natural risk of genetic disease. The risk of
death from cancer for an individual fetus ranged from4
106 to 15  104 for leukemia and 35  104 for solid
cancers. Approximately 20% of fetuses carry a risk above the
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and Wales, the region assessed.12
Prenatal period. The prenatal period is the most sen-
sitive and includes the 0 to 8 days before implantation. This
is also the time when about 50% to 75% of all human
pregnancies abort15 and has been attributed to abnormal
development.16 Because there is such a high incidence of
spontaneous abortion at this time, evaluation of the influ-
ence of radiation as a causative factor is difficult. Multiple
authors have suggested that in animals, radiation-induced
prenatal death might occur at doses of 50 to 100mGy (5 to
10 rad) and above if delivered before implantation.17-20
Brent suggested in 1989 that radiation-induced prena-
tal death in humans occurs at other stages of gestation but
at higher levels 250 mGy (25 rad). The observed effects
include growth retardation, malignancies, and neurologic
effects such as small head size, severe mental retardation,
intellectual deficit, and seizures. Periods have been identi-
fied when the fetus is vulnerable to these effects as follows:
growth retardation, embryonic at 8 to 56 days postconcep-
tion (PC); small head size or microcephaly at 2 to 15 weeks
PC (14-105 days); severe mental retardation at 8 to 15
weeks PC (56-105 days); intellectual deficit at 8 to 15
weeks PC (56-105 days); and seizures at 8 to 15 weeks PC
(56-105 days). A correlation between an increased inci-
dence of childhood cancer and in utero doses of approxi-
mately 20 mGy (2 rad) has been demonstrated by several
authors.21-24 An estimated 1 to 2 cases of childhood cancer
occur per 3000 children exposed to 10 mGy (1 rad) of in
utero irradiation. Although there is some debate, Doll and
Wakeford,25 who have done a review of 40 years of research
on this topic, believe there is compelling evidence to sup-
port in utero radiation as a causative factor inducing child-
hood cancer, even at doses of 10 mGy (1 rad).
Paternal and maternal exposure in year prior to
conception. Case-control studies have been performed to
try to assess radiation effects on maturing reproductive cells
by studying children conceived shortly after population
exposure. Although some authors, such as Gardner,26 have
noted an unusual correlation between paternal exposure and
childhood cancer for workers in a nuclear facility, the data
presented by Gardner and several other authors are hard to
interpret. Thus, there are a variety of hypotheses that need
further investigation. There is no evidence that a child will
be at a greater risk for birth defects from parental exposure
to x-rays or radionuclide medical tests. In the last century,
the number of women exposed to medical radiation has
increased, while the rate of birth defects and miscarriages is
unchanged.10
Dose equivalent to the embryo/fetus. The Massa-
chusetts Department of Health has released recommenda-
tions27 regarding the “Dose Equivalent to an Embryo/
Fetus” that state the following:
“A.)The licensee or registrant shall ensure that the dose
equivalent to an embryo/fetus during the entire preg-
nancy, due to the occupational exposure of a declaredpregnant woman, does not exceed five millisieverts
(0.5 rems).
B.) The licensee or registrant shall make efforts to avoid
substantial variation above a uniform monthly expo-
sure rate to a declared pregnant woman so as to satisfy
the limit in 105 CMR 120.218 (A).
C.) The dose equivalent to the embryo/fetus is the sum of:
1.) the deep dose equivalent to the declared pregnant
woman
2.) the dose equivalent resulting from radionuclides in
the embryo/fetus and radionuclides in the de-
clared pregnant woman.
D.) If the dose equivalent to the embryo/fetus is found to
have exceeded 0.5 millisieverts (0.5 rem) of this dose
by the time the woman declares the pregnancy to the
licensee or registrant, the licensee or registrant shall be
deemed to be in compliance with 105 CMR
120.218(A), if additional dose to the embryo/fetus
does not exceed 0.5 millisievert (0.05 rem) during the
remainder of the pregnancy.”
General requirements regarding administrative
controls. The fetal dose received during fluoroscopic ex-
aminations is influenced by operational factors such as the
settings used on the automatic dose rate control system.
Magnification will reduce the field of view of the intensifier,
and the dose rate to the patient will increase because the
automatic dose rate control compensates for the decrease in
minification gain of the image intensifier. Additional factors
that affect the amount of radiation used in the examination
include the quality of the tube, electronic gain controls, and
the methods used by the manufacturer to control image
clarity and dose rates.12
THE PREGNANT OPERATOR
Careful planning, understanding of the risks, and min-
imization of radiation dose can address many concerns
regarding the pregnant operator. The International Com-
mission on Radiological Protection (ICRP) considers the
unborn child a member of the public when considering the
occupational exposure of the pregnant worker.28,29 Em-
bryos in the earliest stages are most susceptible to radiation.
For example, an exposure of 100 mGy (10 rads or 10,000
mrem) 2 weeks’ gestation may lead to death of the
embryo before clinical pregnancy is even suspected.30,31
Therefore, education regarding the pregnant operator
should be readily available to every female operator of
child-bearing potential. In most cases, pregnant operators
may safely perform procedures without the risk of fetal
injury or death. In general, malformations only occur above
a threshold dose of 100 to 200 mGy (10,000-20,000
mrem) during a pregnancy.32 Between 8 and 15weeks after
conception, fetal exposure of 1000 mGy may reduce IQ by
about 30 points and potentially cause mental retardation.
Fetal exposure at a rate of 6% per Gy may also cause an
increase in childhood (age 0 to 15) cancer risk. Fortunately,
no risk of fetal or childhood effects has been found after
preconception irradiation of either parent’s gonads.32
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standard operating procedures concerning pregnant oper-
ators, but these may vary significantly and may be influ-
enced by state-to-state difference in laws. An institutional
policy inMinnesota, for example, may state that declaration
of pregnancy is not required to work with radiation, but if
such declaration is done, it must be in writing. Other states
or institutions may require confirmatory pregnancy test
results or physician letter to accompany the declaration.
The institutions have an obligation to publish or make their
policies known regardless of the employee’s pregnancy
status at the time of the request.
Once a pregnancy declaration is made, or even before
in some cases, the employee can request an additional
badge to monitor fetal radiation. This abdominal badge (or
fetal badge) is worn in addition to the standard badge and
is secured to the lower abdomen under a lead apron to
estimate the dose received by the fetus when protected by
lead. The employee has the option to request and wear an
abdominal badge regardless of whether a pregnancy decla-
ration has been made. The fetus is most sensitive to radia-
tion effects between 8 and 15 weeks of pregnancy.32 This
period is often before the pregnant worker may announce
her pregnancy to coworkers or supervisors, and therefore
she may request a fetal badge before actually declaring
pregnancy. The purpose of the fetal badge is to assure that
the maximum radiation dose to the fetus of 500 mrem over
the entire gestational period is not reached. This radiation
monitoring is done in addition to the standard collar badge,
and the dose should be reported monthly during preg-
nancy.
Because radiation dose is cumulative, every effort to
reduce exposure should be taken in the pregnant operator.
This includes minimizing fluoroscopy time, possibly by
limiting less experienced operators from using the fluoros-
copy pedal or controls. Careful planning to reduce unnec-
essary imaging or using ultrasound guidance when possible
may be used as long as it does not affect patient care or
interventional outcomes. The pregnant interventionalist
may consider stepping away (ideally6 feet) away from the
table, or even into the anteroom, during imaging runs.
Doubling the distance between the operator and the radi-
ation source will reduce the exposure by four. If the preg-
nant operator cannot step away from the table, movable
lead shields should be used and placed between the x-ray
beam and the operator. In addition, collimation of the
radiographic beam by using metal tubes, cones, or dia-
phragms interposed in the path of the beammay reduce the
peripheral portion that reaches the operator.
The extent of exposure of the pregnant operator may
also be dictated by institutional or state mandates. For
example, the radiation policy from an Arizona institution
states that holding or manipulating the patient during
radiographic or fluoroscopic procedures is not permitted
and that declared pregnant individuals are not to approach
2 feet of the primary beam during diagnostic fluoroscopic
procedures. This may prohibit a declared pregnant individ-
ual from working in interventional radiology, cardiac cath-eterization laboratory, gastroenterology endoscopy, or op-
erating a C-arm in surgery.
The principle of “as low as reasonably achievable”
(ALARA) is an important practice in both pregnant and
nonpregnant operators. As discussed, reducing time and
distance from the radiation source is important. Also critical
is the use of protective aprons. The lead equivalence in the
apron varies, as will the transmission of radiation through
the apron. For example, if the lead equivalence in the apron
is 0.75 mm, the transmission through the apron is about
1.1%; if it is 0.5 mm, transmission is about 2.0% to 3.8%; if
it is 0.25 mm, transmission is about 10.4%.33 Most states
have criteria requiring 0.50-mm lead equivalent coverage,
although some states may allow 0.25 mm.
The pregnant operator should be aware of the degree of
apron protection and may consider additional coverage.
For example, wearing wraparound aprons may allow reduc-
tion of exposure from the side or back.34 “Pregnancy” or
“maternity” lead is a commercially available apron that
wraps around or has additional 0.5- to 1.0-mm protection
in the fetal area. If these options are not available, the
pregnant operator may consider wearing an additional pro-
tective skirt, particularly if the standard lead equivalent is
0.25 mm.
Kicken et al35 evaluated the dosimetry of occupation-
ally exposed persons with 0.5-mm lead and compared
different procedures, particularly cerebral angiograms and
percutaneous transluminal angioplasties. The authors cal-
culated that the fetal dose limit would be reached after 208
percutaneous transluminal angioplasty procedures.35 The
evaluation of staff at two cardiac catheterization units wear-
ing torso shielding with 0.25-mm lead equivalent indicated
that the fetal dose limit would be reached after 34 cardiac
catheterizations by a cardiologist or 87 procedures by the
laboratory nurse.36
In the rare circumstance that a woman operator has a
significant exposure during pregnancy, the amount of ex-
posure is critical to decision making. Most protection agen-
cies agree that termination of pregnancy at fetal doses of
100 mGy (10,000 mrad) is not justified based on radia-
tion risk.37 If the fetal dose is between 100 and 500 mGy,
the operator and support staff must make decisions based
on individual circumstances. If fetal doses are 500 mGy,
however, significant fetal damage may have already oc-
curred, and decisions regarding pregnancy termination
must be made based on the stage of pregnancy.
PROGRAM GUIDELINES FOR PREGNANT
VASCULAR SURGEONS, FELLOWS, AND
RESIDENTS
Standard guidelines are important for a variety of rea-
sons. In 2011, more than half of the medical students are
women. This is very different from 1849, when Elizabeth
Blackwell, the first woman to graduate from a medical
school, failed to gain acceptance into a training pro-
gram.38,39 Fortunately, many things have changed in med-
icine for female medical students and residents; currently,
women account for at least half of the medical school
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specialties.
Although women comprise approximately 50% of the
average graduates, they still occupy 25% of training posi-
tions in general surgery and 20% of the vascular fellow-
ship positions.40,41 In the last 8 years, the leadership in
vascular surgery training has made an effort to attract more
qualified women to consider training in vascular sur-
gery.41,42 Some concerns regarding prolonged training
have led to changes in the structure and length of training
as well as the encouragement of role modeling for both
men and women. Thus, the vascular societies recognize the
need to increase the number of female vascular residents or
fellows, developing a new paradigm of training in vascular
surgery.
The integrated 5-year vascular residency program has
been adopted by many vascular institutions and welcomed
with significant enthusiasm by medical students. This vas-
cular residency program is geared to be more efficient in
instructing the vascular and endovascular surgery of today.
This will hopefully be more attractive to women andmen as
it considerably shortens the years of training. Only 18
women applied for the vascular residency in 2008; how-
ever, this number almost doubled in 2009 with 33 women
applicants.
Meanwhile, the type of procedures performed by vas-
cular surgeons has changed dramatically. Numerous re-
ports have shown that endovascular procedures requiring
prolonged exposure to radiation comprise 75% of all
vascular procedures performed in current academic or pri-
vate practices. Therefore, the new vascular residents in their
training are expected to undergo routine exposure to radi-
ation for up to 5 years during endovascular procedures.
This is during the prime of their childbearing age, and it is
quite possible that they may contemplate pregnancy during
these years. A discrepancy in the ability to start a family
while in training between men and women becomes in-
creasingly evident in our vascular and surgical societies. In
recent reports, 64% of male surgical graduating residents
had a family at graduation vs only 15% of their female
counterparts. The difference persisted after graduation,
with 95% of men and 40% of women having children.40,43
This is a real concern among female students and must be
addressed by the surgical societies.
Although prolongedworking hours during training has
been considered the main hindrance in starting a family,
exposure to radiation is also a significant concern. In a
recent survey among female medical students, 31% ex-
pressed concerns regarding exposure to radiation that
might affect their health and their childbearing potential.
This percentage will probably be higher among vascular
residents and fellows participating daily in long endovascu-
lar procedures.
A lack of written policies regarding pregnancy causes
confusion and frustration among candidates applying for
and those already participating in a residency program.
Standardized policies to protect pregnant residents, at least
during the crucial weeks of gestation, and written informa-tion regarding pregnancy and radiation can address con-
cerns up front and prevent loss of potential candidates who
are qualified to enter vascular residencies. A female appli-
cant is likely to be reticent to ask about the existence of such
a policy within the program, fearing that her particular
interest in such policies and pregnancy would affect her
ranking in this already competitive field. A program that is
viewed by women and men as “family friendly” and sensi-
tive to work-family issues would be more attractive to the
current generation of candidates. Furthermore, a program
with clearly written guidelines detailing safety guidelines
regarding the amount of radiation permissible during preg-
nancy and options for fair redistribution of duties and
rotations during pregnancy will guide residents throughout
these years. There exists a certain amount of anxiety regard-
ing consequences of becoming pregnant as a partner in
practice or trainee. A mutual understanding can prevent
animosity and tension amongst co-residents or partners. A
clear acceptance of this type of policy by vascular surgery
leadership will send a strong message to others.
Awareness in other societies. The American Associ-
ation of Program Directors in Radiology identified the
problem early on and in 2006 presented proposed guide-
lines for pregnancy during radiology residency.44 In doing
so, the association initiated surveys to training programs to
assess the degree to which these issues have been addressed
in various programs. In 1987, the lack of policy became
clear when only 14 radiology programs from all the aca-
demic departments and private practices submitted such
written policies.45
From these surveys, they have proposed guidelines to
support trainees and set a standard for those programs. In
2004, however, despite significant encouragement by the
society, only 50% of the radiology resident’s programs had
developed and implemented a written policy or offered
special accommodations for pregnant residents. Further-
more, only 35% of the available policies were distributed to
the applicants during interviews. Interestingly, the specialty
of radiology, despite more flexible work hours, is another
profession that attracts few women. Although half of the
medical school graduates were women in 2005, only 27.5%
of the radiology residents were women.
A proposal for development of guidelines. The de-
velopment of guidelines is something that can potentially
be initiated through the Program Directors of Vascular
Surgery. Contribution from the directors of the training
programs is critical to developing fair and balanced guide-
lines and eventual implementation by the society of vascular
surgery. The following principles should be considered:
1. Clear definition of occupational radiation dose limits
during the 9 months of pregnancy: Most agree that 500
mrem during the entire pregnancy or 50 mrem/mon is
a safe dose. This translates to 100 to 1000 fluoroscopic
examinations of 5 minutes each per gestational month.
2. Strict measures to decrease exposure during fluoro-
scopic procedure/exam include:
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(1.00 mm lead equivalent with double-lead inserts
over the pelvis), which decrease dose by a factor of
nearly 100 compared to standard aprons);
● encouragement of low magnification use during the
procedures and collimation; and
● strict dosimetry and monitoring using a fetal moni-
toring badge and a badge under lead in accordance
with ALARA principles.
3. Delineation of resident role when pregnant and redistri-
bution of responsibilities: pregnant residents should be
reassigned to rotations not exposed to significant radia-
tion at least for the crucial gestational weeks.
4. Pregnant residents should be expected to participate
fully in the residency; however, adjustments in rotation
schedule should be possible with an effort made to
not detract from their experience or that of their
co-residents.
THE PREGNANT PATIENT AND
RADIATION EXPOSURE
Radiation doses have been studied and are well
known for typical diagnostic examinations.46 Therefore,
in patients who are pregnant or potentially pregnant, it is
imperative that special considerations be given. Most diag-
nostic x-ray studies that are performed looking at structures
other than the pelvis, ovaries, uterus, and lumbar spine do
not lead to measurable exposure of radiation to the fetus.
Those studies that have a higher risk of exposure include
x-rays of the lumbar spine, intravenous pyelogram, and
upper and lower gastrointestinal series; studies of the gall-
bladder and gallbladder function, pelvic, hip, and abdomi-
nal x-rays; and specific x-rays of the uterus and fallopian
tubes, such as a hysterosalpingogram. The Health Physics
Society suggests that if any question exists about the
amount of radiation exposure, the radiation safety officer
and the physicist associated with the department perform-
ing the study can calculate the dosage to the fetus.
It is accepted practice to protect the patient and the
fetus by shielding areas most susceptible to the effects of
radiation, limiting the time of exposure, and using alterna-
tive modalities to study areas closest to the developing fetus
whenever possible.47 Companies that manufacture equip-
ment have continually improved the equipment that con-
centrates the radiation dose to limited areas. Software has
been improved to produce better imaging to allow for less
radiation to be administered. Reduction in kilo voltage and
milliampere/second setting was shown recently to reduce
the radiation dosage in pregnant patients undergoing com-
puted tomographic angiography for suspected pulmonary
embolism while maintaining image quality.48
Diagnostic and interventional procedures using fluo-
roscopy can expose patients to radiation. Fluoroscopy and
cine angiography are both used in interventional laborato-
ries. Almost all of the total radiation exposure is caused by
fluoroscopy. These beams are administered in a pulsed
fashion, which allows for decreased doses. Several practices
can be undertaken to minimize the amount of radiation tothe patient. Limiting fluoroscopy time, increasing the dis-
tance from the beam, the use of collimation, limiting the
extent of angling the beam, and lastly, lead shielding can
greatly diminish the dose to the patient and the staff in the
room. It is imperative that the equipment performance and
calibration be tested regularly. Adequate filtration must be
present. A timermust terminate the exposure. Inmost cases
an audible signal will alert the operator to become aware of
exposure time. Exposure rates cannot exceed regulatory
standards. Regulations have been made and facilities have
been mandated to follow them to minimize the radiation
dose to the treating physician, the staff, and the patients.
Endovascular procedures in the pregnant patient.
Fortunately, pregnant women rarely require endovascular
procedures; however, there are certain situations when
fluoroscopy is required to save the life of the mother or the
life of the fetus, or both. Several such case reports have been
published. Endovascular techniques used to place balloons
in the pelvic circulation for control of uterine hemorrhage
have been applied more and more in an attempt to save the
mother’s life. Generally, emergency cesarean section occurs
to save the life of the baby. Studies have shown that
intraoperative blood loss is minimized by this technique,
reducing risks for both the mother and the baby.49
Treatment of pregnant patients with deep venous
thrombosis, with or without pulmonary embolism, has
been studied.50 Vena cava filters have been successfully
used to treat patients with propagation of clot or pulmo-
nary embolism while on anticoagulation, bleeding compli-
cations while anticoagulated, free floating thrombus in the
ileofemoral region, patients with heparin-induced throm-
bocytopenia, and those pregnant patients presenting 1 to 3
weeks before delivery, without any short-termmorbidity or
mortality to the mother or the baby.51
Case reports of maternal life-threatening emergencies
have been published. Cerebral arteriovenous malforma-
tions that present during pregnancy have the risk of re-
bleeding. Generally, conservative management is recom-
mended, with intervention planned after delivery, if at all
possible. Lesion morphology, surgical risk, and timing of
intervention are looked at closely to make the best decision
for the patient.52 Pregnant patients who present with rup-
tured splenic artery aneurysms or renal artery aneurysms
have high incidence of morbidity and mortality regardless
of the treatment method. Case studies exist in which emer-
gent endovascular coil embolizations were undertaken to
save the patient’s life or an endovascular stent was placed in
a pregnant patient with malignant hypertension and renal
artery occlusion. The total fetal dose was calculated to be
0.002 Gy.53
Pregnancy after endovascular treatments. Uterine
embolization has been widely used in the management of
gynecologic and obstetric problems. Studies have shown
that pregnancy is possible after embolization for hemor-
rhage,54 gestational trophoblastic tumors,55 arteriovenous
uterine anomalies,56 and cervical ectopic pregnancy.57
When uterine artery embolization (UAE) for symptomatic
uterine leiomyomata became available, women were coun-
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pregnancy can be achieved after UAE.58
Walker et al59 recently published a study looking at
pregnancy after UAE. Of 1200 women who had under-
gone the procedure, 108 patients were attempting to be-
come pregnant, 56 became pregnant, and 33 had successful
outcomes. These authors found a significant increase in the
numbers of cesarean sections, preterm delivery, postpartum
hemorrhage, miscarriage, and lower pregnancy rates. They
concluded that pregnancy after UAE is possible. The gen-
eral consensus in the literature is that those patients wishing
to retain their ability to become pregnant should undergo
operative intervention. No study exists to date studying the
feasibility of pregnancy after surgical myomectomy vsUAE.
How these procedures affect fertility long term has not
been studied. What can be deduced from the literature is
that there are patients who have undergone UAE and have
been able to become pregnant and successfully deliver.
CONCLUSIONS
Pregnancy poses special considerations in regard to
radiation exposure. Therefore, decisions to expose the
mother must include need for the procedure, consideration
of other modalities to evaluate the condition, knowledge of
maternal and fetal dosage, and fetal gestational age. The
treating physician, assistants, and technologists involved in
the cases must use standard radiation safety practices. Reg-
ular interaction with companies providing the service con-
tracts for the equipment and software packages should be
helpful in keeping the departments updated regarding im-
provements and patient safety. UAE is no longer a contra-
indication for future pregnancy. Patients should be coun-
seled before any procedure regarding risks and benefits.
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